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Abstract
Background/Aim: Previous studies in vitro and in animals in vivo found
that ·-linolenic acid (C18:3ˆ3) may enhance oxidative damage of essen-
tial amino acids. We investigated whether the addition of the long-chain
polyunsaturated fatty acids (LCPUFA) arachidonate (C20:4ˆ-6; AA) and
docosahexaenoate (C22:6-ˆ3; DHA) in the form of egg phospholipids to
infant formula affects plasma amino acid concentrations and indices of
protein metabolism in term infants. Methods: In a double-blind, random-
ized clinical trial, healthy infants were fed from day 5 of life formula with
or without preformed LCPUFA (n = 10 and 12, respectively). At the age of
5 days and 1, 2, 3 and 4 months, blood samples were obtained and ana-
lyzed for plasma amino acids by high-performance liquid chromatography
and for plasma phospholipid fatty acid composition by gas chromatogra-
phy. Results: At the age of 3 months, plasma threonine concentrations
were significantly lower in infants receiving dietary LCPUFA than in con-
trols (124 B 16 vs. 216 B 28 Ìmol/l, p ! 0.05). Values of other plasma
essential amino acids, total protein, albumin, creatinine and urea nitrogen
did not differ between the two feeding groups throughout the study. At the
age of 5 days, plasma phospholipid AA and DHA concentrations were
inversely correlated with histidine concentrations (AA: r = –0.60, p = 0.01;
DHA: r = –0.53, p ! 0.05). At the age of 3 months, DHA concentrations
were inversely related to plasma histidine, methionine and threonine con-
centrations (r = –0.66, –0.62, and –0.64, respectively, p ! 0.05). Conclu-
sions: The dietary LCPUFA supplementation of infant formula used in
this study has no adverse effects on infant plasma amino acid concentra-
tions and indicators of protein metabolism. Nonetheless, the apparent
interaction of LCPUFA with some amino acids in formula-fed infants
warrants further investigation.
OOOOOOOOOOOOOOOOO
ABC
Fax + 41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 1998 S. Karger AG, Basel
0250–6807/98/0424–0195$15.00/0
Accessible online at:
http://BioMedNet.com/karger
Berthold Koletzko, MD, Kinderpoliklinik
Klinikum Innenstadt, Ludwig-Maximilians-Universität
Pettenkoferstrasse 8a, D–80336 München (Germany)
Tel. +49 89 5160 3967/3511, Fax +49 89 5160 4733
E-Mail Berthold.Koletzko@kk-i.med.uni-muenchen.de
Received: February 28, 1998
Accepted: March 24, 1998
W03:ZANUT461XA SIBY
196 Ann Nutr Metab 1998;42:195–201 Decsi/Burus/Koletzko
Table 1. Amino acid spectrum of conventional
infant formula and formula supplemented with ˆ-3
and ˆ-6 LCPUFA (data provided by the manufactur-
er, Milupa GmbH, Austria)
Amino acid
(g/100 g protein)
Conventional
formula
LCPUFA
formula
Alanine 4.3 4.0
Arginine 3.5 4.0
Asparaginea 9.6 8.7
Glutamateb 17.4 18.7
Glycine 1.7 2.0
Histidine 3.5 3.3
Isoleucine 4.3 4.7
Leucine 9.6 9.3
Lysine 7.0 7.3
Methionine 2.6 2.7
Phenylalanine 3.5 4.0
Serine 5.2 5.3
Threonine 6.1 5.3
Tryptophan 1.7 2.0
Tyrosine 3.5 3.3
Valine 5.2 5.3
a Asparagine and aspartate together.
b Glutamine and glutamate together.
Introduction
Breast-fed infants receive considerable
amounts of preformed long-chain polyunsatu-
rated fatty acids (LCPUFA) in human milk
[1], while infants fed conventional infant for-
mula based on vegetable oils do not [2, 3].
Due to the limited capacity of endogenous
LCPUFA synthesis in infancy [4], the differ-
ences in LCPUFA intakes between infants fed
human milk or conventional infant formula
are reflected in the fatty acid composition of
blood plasma, erythrocytes, subcutaneous tis-
sue, retina and brain [5–9]. In view of the pos-
sible importance of ˆ-6 and ˆ-3 LCPUFA
for optimal infant growth and development,
LCPUFA have been added to several infant
formulae in Europe [10, 11].
Results of investigations both in vitro [12]
and in animals in vivo [13] showed that
enrichment of a whey protein-water solution
with ·-linolenate (C18:3ˆ-3) that was sub-
jected to storage for several week may de-
crease the availability of essential amino
acids, apparently due to oxidative degrada-
tion. It has not been studied previously
whether the supplementation of infant formu-
la with LCPUFA may affect the availability
of essential amino acids in human infants.
Here we report our results on plasma ami-
no acid concentrations and indices of protein
metabolism in healthy, term infants fed for-
mulae supplemented with both ˆ-6 and ˆ-3
LCPUFA in a randomized clinical trial.
Subjects and Methods
At the age of 5 days, healthy, full-term, appro-
priate-for-gestational-age infants whose parents de-
cided not to provide breast-feeding were enrolled in
this study. The primary aim of this trial, on which the
calculation of sample size was based, was to evaluate
dietary effects on essential fatty acid status [14]. The
study protocol was approved by the Ethical Committee
of the University Medical School of Pécs, and in-
formed written parental consent was obtained. With
the use of a computer-generated random number table,
the infants were assigned randomly and double-blind
to receive either a conventional infant formula (n = 10,
Pre-Aptamil; Milupa, Salzburg, Austria) based on
whey protein enriched cow’s milk protein with a
casein/whey ratio of 40/60 and vegetable fat or the
same formula supplemented with egg lipids and eve-
ning primrose oil (n = 12).
Macronutrient composition of the two formulae
was identical (36 g/l fat, 15 g/l protein and 72 g/l carbo-
hydrate). The conventional formula contained !0.1%
(wt/wt) LCPUFA without detectable amounts of ara-
chidonate (C20:4ˆ-6, AA) and docosahexaenoate
(C22:6ˆ-3, DHA), the supplemented formula 1.1%
LCPUFA including 0.5% AA and 0.3% DHA. The
amino acid contents of the two formulae were similar
(table 1). Data on intakes of formula volumes could
not be obtained in the healthy infants studied under
ambulatory conditions.
W03:ZANUT461XA SIBY
Long-Chain PUFA and Amino Acids in
Term Infants
Ann Nutr Metab 1998;42:195–201 197
Table 2. Plasma concentrations of AA and DHA in healthy, term infants fed conventional formula (n = 10) or
formula supplemented with ˆ-6 and ˆ-3 LCPUFA (n = 12; mean B SEM)
Age, days
5 30 60 90 120
Arachidonate, Ìmol/l
Conventional formula 484B60 295B32 280B27*** 306B31 266B28**
LCPUFA formula 529B74 385B33 448B29*** 428B94 384B18**
Docosahexaenoate, Ìmol/l
Conventional formula 95B9 62B8** 46B7*** 49B9*** 44B12*
LCPUFA formula 114B69 106B10** 137B12*** 133B26*** 122B11*
* p ! 0.05; ** p ! 0.005; *** p ! 0.0005 between dietary groups.
The infants’ parents were advised to use exclusive
feeding of breast milk or the study formula only during
the study period. At the age of 5 days and 1, 2, 3 and
4 months, venous blood samples were obtained prior
to feeding from all participating infants. Plasma total
protein, albumin, urea nitrogen and creatinine concen-
trations were determined immediately as described
previously [15]. Blood samples for fatty acid and ami-
no acid analyses were collected into tubes containing
ethylenediaminetetraacetate and heparin, respective-
ly, and stored at –20°C until analysis. The fatty acid
composition of plasma phospholipids was analyzed
with high-resolution capillary gas-liquid chromatogra-
phy as previously reported [16].
Plasma amino acid concentrations were deter-
mined with high-performance liquid chromatography
following o-phthalaldehyde derivatization [17]. Brief-
ly, 50 Ìl plasma was deproteinized with 200 Ìl ab-
solute ethanol, and the internal standard (10 Ìl of
1 mmol/l norleucine solution) was added. The super-
natant was alkalinized with sodium-tetraborate buffer
(400 mmol/l, pH 9.5). Primary amines were deriva-
tized with 2-mercaptoethanol. A Beckman System
Gold chromatograph with gradient pump, ultraviolet
detection and a Hewlett-Packard RP AA-572 C18 mi-
crobore column was used for analysis.
Results were evaluated with Minitab for Windows,
release 9 (Minitab, State College, Pa., USA) and are
presented as means B SEM. Student’s unpaired t test
was used for comparison of data between dietary
groups. Differences were regarded as statistically sig-
nificant at p ! 0.05.
Results
Data on growth and the relative contribu-
tions of fatty acids to plasma lipid classes
have been described elsewhere [14]. Growth
did not differ between the two groups. Plasma
phospholipid AA and DHA concentrations
are shown in table 2. At the age of 2 and 4
months, AA concentrations were significantly
higher in infants receiving formula enriched
with LCPUFA than in controls. From the age
of 1 month onwards throughout the study,
DHA concentrations were significantly higher
in infants receiving dietary LCPUFA than in
those fed conventional formula.
Total protein, albumin, creatinine and urea
nitrogen concentrations did not differ between
the two groups at any time point of the study
(table 3). At the age of 3 months, plasma
threonine concentrations were significantly
lower in infants fed formula supplemented
with LCPUFA than in controls (table 4). Nei-
ther plasma histidine and methionine con-
centrations nor the sum of essential ami-
no acid (histidine, isoleucine, leucine, lysine,
methionine, phenylalanine, threonine and va-
line) concentrations differed between the two
groups at any point of the study (table 3).
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Table 3. Plasma total protein, albumin, creatinine and urea nitrogen concentrations in healthy, term infants
fed conventional formula (n = 10) or formula supplemented with ˆ -6 and ˆ -3 LCPUFA (n = 12; mean B SEM)
Age, days
5 30 60 90 120
Total protein, g/l
Conventional formula 58.8B1.4 57.7B1.9 59.9B1.2 60.5B1.8 62.4B2.5
LCPUFA formula 61.3B2.2 56.9B0.7 59.7B1.0 61.0B2.0 62.4B1.3
Albumin, g/l
Conventional formula 41.5B1.0 42.4B1.4 44.5B1.4 46.1B2.1 48.9B1.2
LCPUFA formula 44.1B1.8 42.8B0.6 44.4B1.4 47.0B1.2 44.3B1.9
Creatinine, Ìmol/l
Conventional formula 77.1B9.2 57.9B5.1 57.7B4.4 78.9B12.8 67.5B10.6
LCPUFA formula 84.0B5.0 58.0B4.2 57.4B5.4 55.3B4.4 63.7B5.9
Urea nitrogen, mmol/l
Conventional formula 2.82B0.30 4.19B0.46 4.57B0.35 4.32B0.26 3.80B0.24
LCPUFA formula 3.04B0.66 3.26B0.18 3.53B0.37 4.43B0.27 3.69B0.21
Table 4. Plasma concentrations of histidine, methionine and threonine and the sum of essential amino acid
concentrations in healthy, term infants fed conventional formula (n = 10) or formula supplemented with ˆ -6 and
ˆ-3 LCPUFA (n = 12; mean B SEM)
Age, days
5 30 60 90 120
Histidine, Ìmol/l
Conventional formula 51B6 67B4 77B11 60B7 58B12
LCPUFA formula 59B9 72B8 67B9 41B8 71B10
Methionine, Ìmol/l
Conventional formula 38B3 48B7 50B9 37B4 35B7
LCPUFA formula 43B7 57B6 38B2 24B6 37B7
Threonine, Ìmol/l
Conventional formula 156B11 253B27 241B40 216B28* 171B33
LCPUFA formula 148B18 234B20 167B12 124B16* 202B24
Sum of essential amino acids, Ìmol/l a
Conventional formula 854B64 1,216B58 1,303B130 1,057B85 1,128B161
LCPUFA formula 987B115 1,379B96 1,085B57 959B141 1,121B116
a Sum of histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine and valine concentra-
tions.
* p ! 0.05 between dietary groups.
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Plasma concentrations of aspartate, the
sum of both glutamine and glutamate, gly-
cine, isoleucine, leucine, phenylalanine, ser-
ine, tyrosine and valine did not differ between
the two groups throughout the study (data not
shown). In infants fed formula enriched with
LCPUFA, we found higher concentrations
(Ìmol/l, p ! 0.05) of asparagine at the age of
5 days (29 B 2 vs. 17 B 2) and of arginine at
the age of 1 month (68 B 7 vs. 46 B 7) and
lower concentrations of alanine at the age of
3 months (287 B 33 vs. 467 B 31). No other
differences in alanine, asparagine and argi-
nine values were seen (data not shown).
Plasma phospholipid AA and DHA con-
centrations were used as predictive variables
in linear regression analyses with plasma ami-
no acid concentrations entered as dependent
variables. Significant inverse correlations
were found at the age of 5 days between AA
and DHA values and histidine (r = –0.60, p =
0.01, and r = –0.53, p = 0.04, respectively)
and at the age of 3 months between DHA and
alanine (r = –0.64, p = 0.02), histidine (r =
–0.66, p = 0.03), methionine (r = –0.62, p =
0.03), serine (r = –0.65, p = 0.03) and threo-
nine (r = –0.64, p = 0.02). No other statistical-
ly significant correlation was found.
Discussion
Reactions of protein-bound amino acids
with oxidizing lipids have been reported by
several investigators. Although most amino
acids were reported to be degradable by poly-
unsaturated fats [18, 19], the most sensitive
amino acids appear to be histidine [20], lysine
[12, 13, 21], methionine [12, 13, 22], tyrosine
[23] and to a lesser extent tryptophan [12, 24].
In an in vitro model using whey protein and
methyl linolenate in water, significant losses
of lysine (up to 71%), histidine (up to 57%)
and tryptophan (up to 31%) were observed
during a storage period of 4 weeks [12]. In rat
assays, the bioavailability of lysine and tryp-
tophan were reduced, and net protein utiliza-
tion and true nitrogen digestibility were sig-
nificantly lowered by oxidizing lipids [13].
These findings indicate that modification of
the fat blend of food products may influence
the availability and metabolism of amino
acids.
In the infants studied here, we found
no effect of formula supplementation with
LCPUFA on the plasma concentrations of the
amino acids considered to be most sensitive
to the effect of oxidizing lipids, i.e., histidine,
lysine, methionine, tryptophan, and tyrosine,
throughout the first 4 months of life. More-
over, biochemical indices of protein metabo-
lism considered to reflect protein utilization
and metabolism (i.e., plasma total protein,
albumin, urea nitrogen, and creatinine con-
centrations) did not differ between the two
feeding groups, nor was there any consistent
trend. Hence, we did not find any indication
for an adverse effect of the LCPUFA enrich-
ment of infant formula used here on the bio-
availability of amino acids in healthy term
infants. However, significant inverse correla-
tions were found between plasma concentra-
tions of AA and DHA and concentrations of
five amino acids, including the essential ami-
no acids histidine and methionine. It appears
possible that high availability of LCPUFA in
the infant organism enhances the probability
of oxidative damage of some amino acids by
polyunsaturated fatty acids or by lipid peroxi-
dation metabolites, such as malondialdehyde
[23]. An alternative explanation for these
findings is a possible interaction of LCPUFA
and metabolic turnover of amino acids. In
view of the observed relationship between
arachidonic acid availability and infant
growth [25] and the mitogenic and growth
promoting effect of prostaglandin E2 derived
from arachidonic acid in cell systems in vitro
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[26], it is conceivable that high tissue concen-
trations of LCPUFA might be associated with
an enhanced protein synthesis rate and, there-
by, might induce lower plasma concentrations
of some essential amino acids. It appears
worthwhile to investigate further the potential
relationship between LCPUFA supply and
amino acid metabolism both in experimental
studies and in future clinical trials.
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The European Nutrition Leadership
Programme
The 6th seminar of the European Nutrition Leader-
ship Programme will be held in Luxembourg from
March 11 to March 18, 1999.
The European Nutrition Leadership Programme
regularly aims to organize advanced training seminars
with an emphasis on topics such as communication of
nutrition science, future strategies and new frontiers in
nutrition research, nutrition science and nutrition
health in Europe, and nutrition within European
health policies.
The seminar will be of particular interest to final-
year PhD students and postdoctoral fellows in human
nutritional sciences in Europe.
Upon application thirty candidates will be selected
by an international selection committee. Applications
will be accepted till November 15, 1998. The fee for
participation will be ECU 750.
For further information and application forms,
please contact:
Mrs. Riekie Deibergen-Janssen or
Mrs. Lous Duym-Brookman
VLAG Graduate School
c/o Division of Human Nutrition and Epidemiology
Wageningen Agricultural University
PO Box 8129
NL–6700 EV Wageningen (The Netherlands)
Tel. +31 317 484214/483054
Fax +31 317 483342
E-Mail riekie.janssen@staff.nutepi.wau.nl
E-Mail lous.duym@staff.nutepi.wau.nl
